148 related articles for article (PubMed ID: 35001033)
21. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
[TBL] [Abstract][Full Text] [Related]
22. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives.
Ribeiro L; Gama G; Santos A; Asmar R; Martins L; Polónia J
Blood Press Monit; 2000 Feb; 5(1):11-7. PubMed ID: 10804446
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic criteria of white coat hypertension (WCH): consequences for the implications of WCH for target organs.
Pose-Reino A; Rodríguez-Fernández M; López-Barreiro L; Coleman IC; Estévez-Nuñez JC; Méndez-Naya I
Blood Press; 2002; 11(3):144-50. PubMed ID: 12126260
[TBL] [Abstract][Full Text] [Related]
24. Maximum ambulatory daytime blood pressure and risk of stroke in individuals with higher ambulatory arterial stiffness index: the JAMP study.
Hoshide S; Tomitani N; Kario K
Hypertens Res; 2023 Jan; 46(1):84-90. PubMed ID: 36243763
[TBL] [Abstract][Full Text] [Related]
25. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.
de la Sierra A; Vinyoles E; Banegas JR; Segura J; Gorostidi M; de la Cruz JJ; Ruilope LM
J Hypertens; 2017 Dec; 35(12):2388-2394. PubMed ID: 28723880
[TBL] [Abstract][Full Text] [Related]
27. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis.
Cuspidi C; Rescaldani M; Tadic M; Sala C; Grassi G; Mancia G
J Hypertens; 2015 Jan; 33(1):24-32. PubMed ID: 25380162
[TBL] [Abstract][Full Text] [Related]
28. Development of preeclampsia in pregnant women with white-coat hypertension: a systematic review and meta-analysis.
Hadizadeh S; Shahmohamadi E; Khezerlouy-Aghdam N; Heidary L; Tarafdari A; Hantoushzadeh S; Ayati A; Foroutani L; Ahmadi-Tafti H; Mohseni-Badalabadi R; Vahidi H; Hadizadeh A; Mousavi S
Arch Gynecol Obstet; 2024 Mar; 309(3):929-937. PubMed ID: 37792010
[TBL] [Abstract][Full Text] [Related]
29. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Sacchi N; Guerrieri M; Comparato E; Porcellati C
Blood Press Monit; 1996 Jun; 1(3):217-222. PubMed ID: 10226230
[TBL] [Abstract][Full Text] [Related]
30. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
[TBL] [Abstract][Full Text] [Related]
31. Relations between white coat effect of blood pressure and arterial stiffness.
Cao R; Yue J; Gao T; Sun G; Yang X
J Clin Hypertens (Greenwich); 2022 Nov; 24(11):1427-1435. PubMed ID: 36134478
[TBL] [Abstract][Full Text] [Related]
32. [Predictive factors of hypertension in patients with diagnostic doubts of persistent hypertension].
Mediavilla García JD; Sabio JM; Carrillo Alascio PL; Fernández Torres C; Aliaga Martínez L; Jiménez-Alonso J
Med Clin (Barc); 2002 Oct; 119(11):401-4. PubMed ID: 12381272
[TBL] [Abstract][Full Text] [Related]
33. The impact of age and 24-h blood pressure on arterial health in acute ischemic stroke patients: The Norwegian stroke in the young study.
Saeed S; Waje-Andreassen U; Naess H; Fromm A; Nilsson PM
J Clin Hypertens (Greenwich); 2021 Oct; 23(10):1922-1929. PubMed ID: 34492149
[TBL] [Abstract][Full Text] [Related]
34. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension.
Mancia G; Facchetti R; Grassi G; Bombelli M
Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342
[TBL] [Abstract][Full Text] [Related]
35. Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group.
Shin J; Park SH; Kim JH; Ihm SH; Kim KI; Kim WS; Pyun WB; Kim YM; Choi SI; Kim SK
Korean J Intern Med; 2015 Sep; 30(5):610-9. PubMed ID: 26354055
[TBL] [Abstract][Full Text] [Related]
36. White coat hypertension and obstructive sleep apnea.
Li L; Guo LZ; Li J; Wang Y; Liu X; Lv YH; Ma CS
Sleep Breath; 2015 Dec; 19(4):1199-203. PubMed ID: 25680548
[TBL] [Abstract][Full Text] [Related]
37. Arterial stiffness evaluated by cardio-ankle vascular index (CAVI) in adolescent hypertension.
Mestanik M; Jurko A; Mestanikova A; Jurko T; Tonhajzerova I
Can J Physiol Pharmacol; 2016 Jan; 94(1):112-6. PubMed ID: 26588489
[TBL] [Abstract][Full Text] [Related]
38. Association of circulating miR-155 expression level and inflammatory markers with white coat hypertension.
Huang YQ; Huang C; Zhang B; Feng YQ
J Hum Hypertens; 2020 May; 34(5):397-403. PubMed ID: 31481696
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension.
Sorof JM; Poffenbarger T; Franco K; Portman R
Am J Hypertens; 2001 Sep; 14(9 Pt 1):855-60. PubMed ID: 11587149
[TBL] [Abstract][Full Text] [Related]
40. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
Staessen JA; Beilin L; Parati G; Waeber B; White W
Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
